IPO

With a new celebrity ad, CoreWeave is making a play for AI dominance. But can its specialized tech overcome financial risks and challenge industry giants?

Aucta Pharma launches two rare disease drugs, PYQUVI and ZELVYSIA, betting on a 'branded-generic' model to navigate highly competitive markets.

Industrial conglomerate Schouw & Co. offers a fee for bondholder consent to spin off its aquaculture giant BioMar, a move that could unlock value but alters risk.

China's top pig farmer, Muyuan Foods, raises HK$10.7B in a landmark Hong Kong IPO, fueling a high-tech global expansion into Southeast Asia and beyond.

Canadian biotech Satellos Bioscience seeks a Nasdaq listing and a $50M public offering to advance its promising muscle regeneration drug for Duchenne.

AI-powered reAlpha has launched a new platform to unify the fragmented homebuying journey. Can its integrated approach truly simplify the process for buyers?

After a blockbuster IPO raised nearly $300 million, dermatologist-founded Veradermics is poised to challenge the hair loss market with its new oral pill.

Colombier Acquisition Corp. III, with a board of political and tech heavyweights, has a $299M war chest. Its hunt for a 'patriotic' target begins.

Fidelity sweeps top honors in Corporate Insight’s annual awards, highlighting a fierce digital arms race with Schwab and E*TRADE to win over modern investors.

Global internet leaders convene in Mumbai for ICANN85 to launch new domains and defend a unified web in a pivotal moment for digital governance.

A health-tech firm with a mission for free care and a $1.3B valuation eyes a Nasdaq listing, but its revenue-free history raises critical questions.

Everbright Digital hopes a 1-for-16 reverse stock split will save its Nasdaq listing, but the move raises questions about its metaverse-focused future.

The multiyear agreement makes Baker Hughes the preferred tech provider for Marathon's vast network of oil and renewable fuels facilities across North America.

With major drug approvals on the horizon, Nuvalent's leadership will detail its strategy for its next-gen cancer therapies at an influential investor summit.

Forgent Power Solutions prices its IPO at $27 a share, targeting a massive valuation fueled by intense demand from data centers and grid modernization.

The world's largest jeweler misses 2025 growth targets and issues a sober 2026 forecast, prompting a major strategic shift to platinum-plated jewelry.

With the hire of legal tech veteran Keith Zoellner, Lineal signals an aggressive push to dominate the eDiscovery market with its AI-powered hybrid model.

The first new F1 team in a decade, Cadillac is embedding TWG AI from day one, betting on an intelligence-native approach to challenge the grid in 2026.

Ewan Henderson, former Informatica leader, joins Celonis to help Fortune 500 firms unlock tangible value from their complex AI and process investments.

The AI boom runs on powerful chips that generate immense heat. Discover how the once-overlooked HVAC industry is now a critical infrastructure investment.